Please provide your email address to receive an email when new articles are posted on . 38% of patients with cutaneous lupus erythematosus displayed evidence of positive interferon (IFN)-alpha ...

Please provide your email address to receive an email when new articles are posted on . The addition of interferon alfa to temozolomide significantly extended survival among patients with newly ...

RAGE ligand S100A8/A9 as a novel prognostic biomarker for high-risk melanoma patients. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a full text ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Intron A is an injectible recombinant ...

Pharmacokinetic studies have provided a rationale for enhanced IFN dosing. The initial decline in serum HCV RNA levels seen after a single dose of IFN therapy is believed to reflect a direct antiviral ...

The ECOG began a randomized trial in the mid-1980s evaluating the use of IFN-α2a given in combination with doxorubicin, cyclophosphamide, vincristine and prednisone as treatment for NHL. Results from ...

Alzheimer’s disease (AD), the most common type of dementia, progressively impairs memory, concentration and the ability to learn new things and accomplish everyday activities. Although scientists do ...

Interferon therapies are well established as treatment options for some types of cancer, but they have not been used to treat cancers characterized by the overproduction of blood cells. The FDA has ...